PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 53: Articles 26001-26500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Prevalence of use of contraception: the variety of concepts and definitions contributing to problems of measurement and data comparability.
  2. Prevention of oral contraceptive failure: medical psychology and practical problems. [Prevention des echecs de la contraception orale: psychologie medicale et probleme pratique.]
  3. Prevention of recurrent menstrual psychosis by an oral contraceptive.
  4. Primary cancer of the liver in a woman on oral contraceptives. [Cancer primifif du foie chez une femme prenant des contraceptifs oraux.]
  5. Primary health care with special reference to nutrition, MCH and family planning.
  6. Primary health care with special reference to nutrition, MCH and family planning.
  7. Primary hepatocellular carcinoma developing in a female patient on long term oral contraceptives: a case report.
  8. Principal legislative texts related to family planning. [Principais textos legislativos relacionados com o planejamento familiar.]
  9. Probable stenocardial effects of combined oral contraceptives. [Probabili effetti stenocardici dei contraccettivi orali di tipo combinato.]
  10. Problems of internal medicine which can occur during contraceptive use. [Internmedizinische Probleme bei der Kontrazeption.]
  11. Problems related to the recognition of intrauterine contraceptive devices by ultrasound.
  12. Proceedings of the First Bi-Annual Seminar on Family Planning Operations Research.
  13. Proceedings of the Thirteenth Annual Conference, Association for Population/Family Planning Libraries and Information Centers--International, Denver, Colorado, April 8-10, 1980. Population/family planning resources: plugging into the 1980s.
  14. The PROFAMILIA Baseline Survey: a fertility and contraceptive study in the coffee producing areas of three Colombia departments.
  15. Profile of family planning service personnel for barrier method acceptability study.
  16. Progestational contraception: a life saver. [La contraception progestative: une planche de salut.]
  17. A progestogen-releasing intracervical contraceptive device: fabrication and preliminary clinical evaluation.
  18. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-mcg oestrogen preparations.
  19. Program report [of the Central America regional seminar-workshop entitled] New Focuses of Family Planning Program Administration: Analysis of Contraceptive Prevalence Surveys and Other Program Data, [held in] Antigua, Guatemala, May 25-30, 1980.
  20. Progress report on the Thai Integrated Family Planning and Parasite Control Programme, Sept. 1978-Sept. 1979.
  21. Prolactin and contraception. [Prolactine et contraception.]
  22. Promotion of postpartum contraception using MCM as a tool of management.
  23. Prospective studies on the risks and benefits of contraceptions.
  24. A prospective study of the effects of the progestagen content of oral contraceptives on measures of affect, automatization, and perceptual restructuring ability.
  25. Prospects for improved contraception.
  26. Provide information about gossypol as an oral contraceptive for men.
  27. Psychological aspects of natural family planning.
  28. Psychological factors: counseling and motivation of contraceptive patients.
  29. Psychosomatic considerations in surgical contraception (author's transl) [Psychosomatische aspekte bei der chirurgischen kontrazeption.]
  30. Public influence on government policy: family planning and manpower development in Tunisia.
  31. Public policy-making theory and the case of family planning.
  32. Publication of report on contraceptive prevalence in Thailand: highlights. [Memorandum]
  33. Quality and comparability of family planning data from surveys and service statistics: a review paper.
  34. Quantitative morphological investigations in livers and liver tumors after taking contraceptives (author's transl) [Quantitativ-morphologische Untersuchungen an Lebern und Lebertumoren nach Einnahme von Kontrazeptiva.]
  35. Quantitative morphological investigations in livers and liver tumors after taking contraceptives (author's transl) [Quantitative-morphologische untersuchungen an lebern und lebertumoren nach einnahme von kontrazeptiva.]
  36. Radio campaigns and family planning in Colombia, 1971-1974.
  37. Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl) [Radioimmunologisnce Studie uber den Einfluss hormonaler Kontrazeptiva auf den Progesteronspiegel des Speichels.]
  38. A randomized double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens.
  39. A randomized prospective study of the use-effectiveness of two methods of natural family planning.
  40. A randomized study of metabolic effects of four oral contraceptive preparations containing levonorgestrel plus ethinyloestradiol in different regimens.
  41. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives.
  42. The rationale for a new triphasic contraceptive.
  43. Recent developments in steroidal contraception.
  44. Recent evolution in the National Family Planning Program. [Evolution recente du Programme National de Planning Familial.]
  45. The recent information regarding contraception.
  46. Recent trends in fertility, abortion, and contraception in Cuba.
  47. Recognizing malignancy in intrauterine contraceptive device users.
  48. Recommendations for contraception in teen-age girls (author's transl) [Welche kontrazeptiven methoden sind fur jugendliche geeignet.]
  49. Recommendations of the Second Expert Group Meeting on Methods of Measuring the Impact of Family Planning Programmes on Fertility: report of the Secretary-General.
  50. Reduction of menstrual blood loss by Naproxen in intrauterine contraceptive device users.
  51. Regional Seminar on Nutrition and Family Planning: final report.
  52. Regulation of implantation as a contraceptive method. [La regulacion de la implantacion como metodo anticonceptivo.]
  53. Reinforcement of family planning service strategy in India.
  54. Relationship of estrogens and oral contraceptives to endometrial cancer in animals and women.
  55. The relationship of knowledge to perceived benefits and risks of oral contraceptives among college women.
  56. Relative sensitivity of postpartum gestational diabetic women to oral contraceptive agents and other metabolic stress.
  57. Release of 19-nor-testosterone type of contraceptive steroids through different drug delivery systems into serum and breast milk of lactating women.
  58. Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during menstrual cycles controlled by oral contraceptive preparations.
  59. Reply to Dr. Billings [concerning two methods of natural family planning] [letter]
  60. Reply to Dr. Hilgers [concerning two methods of natural family planning] [letter]
  61. Report covering the period July 25 to August 9, 1980, liaison visit to El Salvador Commercial Contraceptive Marketing Program, Contract No. AID/pha C-1155 [memorandum]
  62. Report of National Conference on Population Management as a Factor in Development Including Family Planning, held at Letsie Hall, Lesotho Agricultural College, Maseru, Lesotho, 26 April-29 April 1979.
  63. Report of natural family planning in Peru.
  64. Report of the evaluation of UNFPA assistance to the National Family Planning and Sex Education Programme of Costa Rica.
  65. The report of the family planning observation mission to China, June 27th-July 10th, 1980.
  66. Report of the panel on the effects of steroidal contraceptives on Asians regional medical committee, IPPF--ESEAOR.
  67. Report of the Second Study Directors' Meeting on the Study of Impact of Family Planning Programs: Multivariate Analysis of Family Planning Programs' Contribution to Fertility Change, Bangkok, Thailand, May 26-28, 1980.
  68. A report of UNFPA/EWPI Technical Working Group Meeting on the Role of Incentives in Family Planning Programs, East-West Center, Honolulu, Hawaii, May 15-16, 1979.
  69. Report on A.K.A.P. study of 1,000 Thai masseuses concerning family planning, pregnancy and abortion, venereal disease infections, and narcotics addiction.
  70. Report on consultation to the Jamaica Family Planning Association.
  71. A report on technical assistance in revising training activities in family planning and developing a training assistance strategy in Peru.
  72. A report on technical assistance to the Jamaica Contraceptive Retail Sales Program.
  73. A report on the development of IEC materials for the National Family Planning and Population Office in Tunisia.
  74. Report on the feasibility of family planning, nutrition and parasite control integration.
  75. A report on the knowledge of, and attitude toward contraceptive methods of students in National Chung-Hsing University (author's transl)
  76. Report on the Regional Seminar on the Use of Paramedics for Contraceptive Service Delivery, Dacca, Bangladesh, October 22-25, 1979.
  77. Research and new developments in intrauterine contraception. [Abstract]
  78. Research in natural family planning.
  79. Research on acrosine: a good track toward contraception? [Recherches sur l'acrosine: une piste pour la contraception?]
  80. Research on the effects of hormonal contraceptives on lactation: current findings, methodological considerations and future priorities.
  81. Resettlement in low-cost housing schemes: a case study of knowledge, attitude and practice of family planning in the Cheras low-cost housing scheme.
  82. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
  83. Response [to ethics of contraceptive development and deployment]

     

  84. Response [to ethics of contraceptive development and deployment]
  85. Response [to ethics of contraceptive development and deployment]
  86. Response: [contraceptive development and deployment from a provider's perspective]
  87. The responsibility "connection": divorce, contraception, abortion, euthanasia.
  88. Responsible parenthood and the morality of birth control methods.
  89. A retrospective view of oral contraceptives.
  90. Return of ovulation after abortion and after discontinuation of oral contraceptives.
  91. Reversibility of alterations induced by sexual steroids in various serum protein fractions, following application of hormonal contraceptives (authors' transl) [Zur reversibilitat sexualsteroidinduzierter veranderungen verschiedener serumproteinfraktionen nach applikation hormonaler kontraceptiva.]
  92. Reversible contraception.
  93. A review of the proceedings of the first seminar of future trends in family planning in the developing world (Parts I and II)
  94. A review on enzyme changes in serum and urine due to treatment with drugs (tuberculostatics, contraceptive medication, diagnostics and drugs in renal diseases)
  95. A review on future perspectives of Korean National Family Planning Program based on population and family research findings (author's transl)
  96. Reviewing birth control methods for new clinic patients.
  97. Risk, fertility, and family planning in a Bangladesh village.
  98. The role and challenge of female sterilization in family planning programs.
  99. The role of family planning availability and accessibility in family planning use in developing countries.
  100. The role of male sterilization in family planning programs.
  101. The role of non-physicians in family planning.
  102. The role of oral contraceptives in cervical infection with sexually transmitted diseases.
  103. The role of oral narratives in dissemination of family planning information in rural Africa.
  104. Role of paramedical personnel in IUD and family planning. [Abstract]
  105. The role of research and training in family planning programmes.
  106. The role of the Family Planning Association of Kenya in family life education programmes for youth.
  107. The role of the pharmacist in the delivery of family planning services to college students.
  108. The role of vaginal contraceptives in preventing venereal disease and pregnancy.
  109. Role of WFS data in the analysis of family planning programmes.
  110. Rubella and oral contraceptives. [Letter]
  111. Rupture of benign hepatic tumors. Effects of oral contraception: 2 cases. [Tumeurs hepatiques benignes rompues. Influence de la contraception orale: a propos de 2 cas.]
  112. Rural development and family planning behavior in Bangladesh villages.
  113. Rural users information requirements for social welfare and family planning.
  114. Safety of modern contraceptive technology: current status.
  115. Scanning and transmission electron microscopy of material adherent to intrauterine contraceptive devices.
  116. Second Five Year Plan: population control and family planning.
  117. Selected family planning and general health profiles in a teen health clinic.
  118. Selection and use of animals in contraceptive research.
  119. Seminar on the Effect of Internal Migration, Urbanization and Resettlement in the IGCC Region on its Population/Family Planning Programmes.
  120. Serum copper and zinc in hormonal contraceptive users.
  121. Serum high density lipoprotein cholesterol levels in women using a contraceptive injection of depot-medroxyprogesterone acetate.
  122. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations.
  123. Serum phospholipid fractionation after the use of long-acting progestational contraceptives.
  124. Sewing machines and bank loans, farming and family planning.
  125. Sex hormones and related compounds, including oral contraceptives.
  126. Sexual activity, contraceptive use and pregnancy among metropolitan-area teenagers: 1971-1979.
  127. Sexual and contraceptive experience of young unmarried women in the United States, 1976 and 1971.
  128. Sexual experience and responses to a birth control film.
  129. Sexual experience, birth control usage, and sex education of unmarried Canadian University students: changes between 1968 and 1978.
  130. Sexual knowledge and attitudes of adolescents: relationship to contraceptive use.
  131. Sexuality and birth control in social and community work.
  132. Shift the focus of family-planning work to one couple giving birth to one child--an investigative report on family-planning conditions in Shifang County.
  133. A short history of 4,000 years of birth control.
  134. Sichuan People's Government stresses planned parenthood.
  135. Side effects of using modern contraceptive methods for a period of 9192 cycles. [Stranichni iavleniia pri prilagane na suvremenni metodi na kontratseptsiia za srok ot 9192 tsikula.]
  136. Situational, attitudinal and normative determinants of coital, contraceptive and conceptive behavioral intentions: an integration of social exchange theory and the Fishbein model.
  137. Six years' experience with the T Cu 220C intrauterine contraceptive device.
  138. A small library in family planning. 3rd ed.
  139. The Social and Demographic Aspect of Family Planning.
  140. The social and demographic aspect of family planning: on the analysis and evaluation of family-planning projects in developing countries.
  141. The social effects of contraception.
  142. Social marketing in family planning: some practical issues for policy makers.
  143. The social marketing of contraceptives in Mexico.
  144. Social marketing of family planning.
  145. Social-psychological and communication factors in discontinuance of birth control use in the Dominican Republic.
  146. Socio-cultural barriers to acceptance of family limitation in India: an examination of these barriers and the extent to which Indian family planning motivational programs are dealing with them.
  147. Sociodemographic and psychological aspects of contraceptive practice. [Aspects socio-demographiques et psychologiques de la pratique contraceptive.]
  148. The sociopolitics of contraception.
  149. Some aspects of population dynamics and family planning in Jamaica.
  150. Some aspects of the family planning programme in rural Bangladesh: a case study.
  151. Some considerations on the integration of family planning programs.
  152. Some social aspects of providing contraception for under-16-year-olds.
  153. Sources of demographic data for family planning programme.
  154. Specific serum protein levels in women using intrauterine contraceptive device.
  155. Spontaneous foetal losses in women using different contraceptives around the time of conception.
  156. Spontaneous mesenteric venous thrombosis, a rare complication of oral contraceptives (author's transl) [Primaere Mesenterialvenenthrombose, eine seltene Komplikation oraler Ovulationshemmer.]
  157. Sri Lanka: sterilization bonus announced in Sri Lanka; new CBD experiments in Sri Lanka; orchids and family planning.
  158. Standard specifications for rubber contraceptives (condoms). American National Standard ANSI/ASTM D 3492-77.
  159. Standards and quality control in contraception.
  160. State of the endometrium and endo- and ectocervix in women halting the use of intrauterine contraceptives. [Sostoinie endometriia, endo-i ektotserviksa u zhenshchin, prekrativshikh pol'zovat'sia vnutrimatochnymi kontratseptivami.]
  161. Status of contraceptive technology development.
  162. The status of management research in family planning programs in Latin America and the Caribbean.
  163. Sterilization in family planning. The psychology of voluntary sterilization (author's transl) [Endgultige frunchtbarkeitsverhutung in der familienplanung. Zur psychologie der freiwillinger sterilisation.]
  164. Sterilization Services at Planned Parenthood of Maryland.
  165. Steroid and nonsteroid postcoital contraceptives. [Steroidnye i nesteroidnye kontraseptivy postkoitalnogo deistviia.]
  166. Steroid contraception.
  167. Stochastic models for the evaluation of family planning programs with application to Nepal.
  168. Strokes and contraceptive medication.
  169. Studies in family planning information education and communication in Uttar Pradesh: a review.
  170. Studies of pituitary gonadotropin response to graded GNRF injections in women using a low-estrogen oral contraceptive for six months.
  171. Studies on ethanol and oral contraceptives: feasibility of a hepatic-gonadal link.
  172. Studies on hemoglobin AI and AIC in the women administering oral contraceptives [abstract]
  173. Studies on the effect of injectable contraceptive on reproductive function of animals.
  174. Studies on the effect of injectable contraceptives on reproductive function in animals.
  175. Study findings on evaluation of integrated family planning programme performance.
  176. Study of blood pressure in women taking oral contraceptives.
  177. A study of interaction of a low-dose combination oral contraceptive with anti-tubercular.
  178. A study of interaction of low-dose combination oral contraceptive with ampicillin and metronidazole.
  179. A study of male motivation for family planning.
  180. A study of Noristerat (injectable contraceptive) on 100 patients in Dacca Medical College Hospital.
  181. A study of socio-economic determinants of family planning practice based on cross-country regressions.
  182. A study of socioeconomic determinants of family planning practice based on cross cultural regressions.
  183. Study of the feasibility of a contraceptive social marketing project in Liberia.
  184. A study of the use of contraceptives by a town and a country population of northern Italy. [Indagine sull'uso di mezzi contraccettivi in una poplazione di citta e di provincia del nord-Italia.]
  185. Study of the use of contraceptives by a town and a country population of northern Italy. [Indagine sull'uso di mezzi contraccettivi in una popolazione di citta e di provincia del nord-Italia.]
  186. Successful pregnancy soon after oral contraceptive-associated malignant hypertension.
  187. Summary report: Evaluation of two AID-financed health and family planning projects in Nepal.
  188. Surgical male contraception. [Contracepcao cirurgica masculina.]
  189. A survey of the Haringey Domiciliary Family Planning Service 1968-1975.
  190. Synthetic estro-progestational (contraceptive) agents and cerebral ischemic complications: cerebral psuedo-tumors, thrombosis of intracranial venous sinuses: sixty cases. [Oestroprogestatifs de synthese (contraceptifs) et accidents ischemiques cerebraux: pseudo-tumeurs cerebrales, thrombose des sinus veineux intracraniens: a propos de soixante cas.]
  191. Systemic and local delivery of contraceptive steroids using biodegradable microcapsules.
  192. Taking the profits out of birth control: the cervical cap may be safer, too.
  193. Teaching family planning management and evaluation skills.
  194. Technical assistance report on the "Family of the Future" contraceptive sales program Cairo, Egypt.
  195. Teenage pregnancy. Pt. 1. Contraception and sexuality behavior (author's transl) [Gravidez na adolescencia. pt 1. conduta frente a anticoncepcao e ao sexo.]
  196. The teenager and the family planning experience.
  197. The temperature behavior of the gingiva on application of hormonal contraceptives (author's transl) [Das Temperaturverhalten der Gingiva bei Anwendung hormoneller Kontrazeptiva.]
  198. A ten year clinical investigation of injectable contraceptives. [Investigacion clinica sobre diez anos de anticonceppion inyectable mensual.]
  199. Thailand: progress report of the Integrated Family Planning and Parasite Control Project.
  200. Theatre and operating manual for contraceptive surgery.
  201. Third evaluation of the Thailand National Family Planning Program.
  202. Thromboembolic phenomena and oral contraceptives.
  203. Thrombosis and oral contraception.
  204. Thyroid function in women taking oral contraceptives (authors' transl) [Utjecaj oralnih kontraceptiva na metabolizam hormonz stitnjace.]
  205. The timing and extent of examinations of women using oral contraception--a discussion.
  206. The timing of laparoscopic sterilization in relation to prior contraception.
  207. Tomorrow's parents--today: a focus on the role of youth in family planning. Report of a seminar, New Delhi, 4-5 November, 1980.
  208. Toward a predictive model of family planning. [Hacia un modelo predictivo de la planificacion familiar.]
  209. Towards an effective family planning communications strategy.
  210. Towards effective family planning programming.
  211. Trace element intake and the influence of hormonal contraceptives on the trace elements in feces and urine. [Die Spurenelementaufnahme und der Einfluss hormonaler Kontrazeptiva auf den Spurenelementgehalt von Stuhl und Urin.]
  212. Traditional birth attendants and family planning.
  213. Training and manpower development in surgical contraception programs.
  214. Training for family planning work in Africa.
  215. Training of primary care physicians in family planning: reproductive health and ambulatory gynecology in an academic institution.
  216. A training program in family planning for medical students and nurse midwives. [Abstract]
  217. Transcortin as an indicator of estrogenic potency in oral contraceptives.
  218. Translocation and inversion of the intrauterine contraceptive device (Author's transl) [Translocacao e inversao de dispositivos intra-uterinos.]
  219. A triphasic oral contraceptive: Logynon and Trinordiol.
  220. Triphasic oral contraceptives.
  221. Trophoblastic markers in women using intrauterine contraception.
  222. Twenty-seven strategies for teaching contraception to adolescents.
  223. Two becomes one: a new attempt at birth control in the People's Republic of China. [Zwei wird zu eins: ein neuer Anlauf zur Geburtenkontrolle in der Volksrepublik China.]
  224. Two methods of natural family planning [letter]
  225. Two-year report, Dhaal and Gulaf in Nepal, June 1, 1978 - May 31, 1980. The HMG-USAID-Westinghouse Nepal CRS Project (Nepal Family Planning/Maternal and Child Health Project)
  226. U.S./Mexico Border survey of Maternal and Child Health/Family Planning, 1979. Advanced report.
  227. Ultrastructural study of blood vessels in human endometrium exposed to progesterone-releasing intrauterine contraceptive devices.
  228. Understanding the pill: basic information for distributors and sellers of oral contraceptive pills.
  229. Unisex birth control chemical.
  230. Unruptured ectopic pregnancy and intrauterine contraceptive device demonstrated by grey-scale ultrasound.
  231. Urban family and family planning in India.
  232. Urban-rural differentials in contraceptive use.
  233. Use of automated record linkage to measure patient fertility after family planning service.
  234. Use of contraception among married women in New South Wales, Australia.
  235. The use of contraceptive prevalence survey data to validate family planning program service statistics.
  236. Use of contraceptive prevalence survey data to validate family planning program service statistics: references and updated tables and figures.
  237. Use of contraceptives in women under 18: data of the Center for Family Planning, University of Rome. [La contraccezione nella minore di 18 anni presso il Centro di Pianificazione Familiare dell'Universita di Roma.]
  238. The use of different hormonal contraceptives and IUDs in anemic women: a six-month follow-up.
  239. The use of different oral contraceptives and IUDs in anemic women: six month follow up.
  240. Use of family planning in Haiti: a comparison of survey data and service statistics.
  241. Use of family planning services.
  242. Use of low-dosage oral cyproterone acetate as a male contraceptive.
  243. Use of oral contraceptives during lactation: can fertility be increased?
  244. The use of oral contraceptives in the treatment of hyperandrogenism.
  245. The use of prompts and incentives to increase cervical cytology in a family planning clinic.
  246. Use of the Cu-7 device in a family planning clinic.
  247. The use of ultrasounds in real time in the localization of intrauterine contraceptive devices (author's transl) [Evidenziazione mediante ultrasuonografia in temporeale di dispositivi contraccettivi intrauterini criptoritenuti.]
  248. Use-effectiveness and safety of oral contraceptives in rural Bangladesh: Sulla case study.
  249. Use-effectiveness of standard-dose and low-dose oral contraceptives in Dacca.
  250. The user perspective: an evolutionary step in contraceptive service programs.
  251. User preferences for contraceptive methods in India, Korea, the Philippines, and Turkey.
  252. The utility of person and situation variables as predictors of teen contraceptive behavior.
  253. Utilization of para-medical and non-clinical workers in family planning in IOR - [Indian Ocean Region]: policies and programs.
  254. Utilizing research to manage a family planning project.
  255. Vaginal chemoprophylaxis in the reduction of reinfection in women with gonorrhoea: clinical evaluation of the effectiveness of vaginal contraceptive.
  256. Vaginal contraception: realities and perspectives. [La contraception vaginale: realite et perspectives.]
  257. Vaginal contraception: the old and the new.
  258. Vaginal contraceptive drug products for over-the-counter human use; establishment of a monograph; proposed rulemaking.
  259. Vaginal contraceptives: available but-.
  260. Vaginal steroidal contraception.
  261. Value conflicts in biomedical research into future contraceptives.
  262. The value of birth control.
  263. Variation of ethinylestradiol blood levels among healthy women using oral contraceptives.
  264. Variations in serum copper and ceruloplasmin activity following a long term intake of combined oral contraceptives in Iranian women.
  265. Vascular and perivascular changes in the endometrium of women using steroidal contraceptives.
  266. Vascular thrombosis in the upper extremity: case report implicating a relationship between trauma, oral contraceptives, and smoking.
  267. Vesico-uterine fistula treated by amenorrhoea induced with contraceptive steroids: two case reports.
  268. Vitamin nutritional status of women using oral contraceptive pills.
  269. Voluntary sterilization: its demographic impact in relation to other contraceptive methods.
  270. Wallenberg's syndrome in a young girl following long-term use of a contraceptive agent. [Hetsyndroom van Wallenberg bij een jonge vrouw na langdurig oraal gebruik van een contraceptivum.]
  271. The Walnut Creek Contraceptive Drug Study: a prospective study of the side effects of oral contraceptives. Vol. III, an interim report: a comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives.
  272. Weighing the benefits and risks of contraceptive methods.
  273. WFS finds wide knowledge of family planning in Jamaica.
  274. What has contraception changed in France? [Qu'est-ce que la contraception a change en France.]
  275. What is new in hormonal contraception? (Author's transl) [Quoi de neuf en contraception hormonale?]
  276. What more can the para-medics do in family planning?
  277. What more can the para-medics do in family planning?
  278. What type of contraceptive method can the physician recommend? [Welche kontrazeptive methode kann der arzt emphfehlen.]
  279. What we have learned about family planning in the Calabar Rural MCH/FP Project (Nigeria)
  280. Why is it difficult to carry out birth control work in Wenzhou?
  281. Widespread contraceptive use found in Britain: condom popular; two-child families preferred.
  282. Woman-controlled birth control: a feminist analysis of natural birth control.
  283. Women in Management Seminar--Workshop 5 on Planning and Management of Service Delivery Programs in Family Planning, Health and Development, May 5 to June 6, 1980.
  284. Workshop/Seminar for more Effective Promotion and Management of Integrated projects (Family Planning, Parasite Control and Nutrition)
  285. Worldwide laws and policies on contraception, abortion and sterilization affect service provision.
  286. Contraceptive practice and repeat induced abortion: an epidemiological investigation.
  287. Carbohydrate metabolism prospectively studied in women using a low-estrogen oral contraceptive for six months.
  288. Circulatory disease in association with oral contraceptive use.
  289. Use and acceptance of the "paper pill": a novel approach to contraception.
  290. Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism.
  291. Determinants of family planning performance at PHC level: some observations from a mass vasectomy campaign in Gujarat.
  292. Ethnic differences in family planning acceptance in rural Guatemala.
  293. Further results about pregnancy and childbirth after use of oral contraceptives (author's transl) [Weitere Ergebnisse uber Schwangerschaft und Geburt nach Anwendung von Ovulationshemmern.]
  294. Influences on family planning acceptance: an analysis of background and program factors in Malaysia.
  295. Management issues in the organization and delivery of family planning services.
  296. A new principle of injectable depot contraceptives. I. Drug selection and studies in monkeys.
  297. Oral contraceptives and the risk of thrombosis. [Letter]
  298. Pituitary adenoma and oral contraceptives: a case-control study.
  299. Plasma levels of active ingredients after single and repeated administration of a new oral contraceptive containing 2 mg of cyproterone acetate and 50 micrograms of ethinyl estradiol (Diane) to five young women.
  300. Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters.
  301. The progestational activity of different gestagens used for human contraception in the beagle bitch.
  302. Spread of the use of modern contraceptive methods in France: 1971-1978 (author's transl) [La diffusion des methodes contraceptives modernes en France de 1971 a 1978.]
  303. Contraceptive research and development.
  304. Contraceptive responsibility among male university students.
  305. Contraceptive risk-taking in white and black unwed females.
  306. Contraceptive sterilization approved by two-thirds of adult Americans, recent Gallup shows.
  307. Contraceptive supply to single young persons.
  308. Contraceptive technology in the future. [Editorial]
  309. Contraceptive technology relevant to Indian conditions: report of a biomedical study group.
  310. Contraceptive tubal sterilization rate increases more than twice during the period 1970-1976.
  311. Contraceptive usage in rural areas. [El empleo de anticonceptivos en areas rurales.]
  312. Contraceptive use and demographic trends in El Salvador.
  313. Contraceptive use and effectiveness.
  314. Contraceptive use and subsequent fertility.
  315. Contraceptive use and subsequent fertility. [Fecondabilite apres different modes de contraception.]
  316. Contraceptive use in Australia.
  317. Contraceptive use in the Indonesian village distribution system: continuation and effectiveness.
  318. Contraceptive use pattern and prevalence, 1976-1979.
  319. Contraceptive use-effectiveness and the American adolescent.
  320. Contraceptive uterotubal plug has high reversibility potential.
  321. Contraceptive utilization: United States.
  322. Contraceptive vasectomy: study of 100 cases. [La vasectomie contraceptive: etude a propos de 100 cas.]
  323. Contraceptive patterns in women who have undergone a legal abortion.
  324. The contraceptive pill - still controversial.
  325. Contraceptive pill in women over 40. [La pilule contraceptive chez la femme do 40 ans et plus.]
  326. Contraceptive pitfalls [letter]
  327. Contraceptive potential of (d-leu6, des-gly-NH210, pro-ethylamide9)-gonadotropin releasing hormone. (Abstract only)
  328. Contraceptive practice among New Zealand women.
  329. Contraceptive practice and its impact on birth rates of Maharashtra.
  330. Contraceptive practice before and after therapeutic abortion. 2. use-effectiveness of oral contraceptives and intrauterine devices.
  331. Contraceptive practice in France in 1978.
  332. Contraceptive practices in France (1978) [Les pratiques contraceptives en France 1978.]
  333. Contraceptive practices in two language groups in South Africa.
  334. Contraceptive Prevalence Survey: Colombia. Summary report.
  335. Contraceptive product development in public-sector programs.
  336. Contraceptive properties of luteinising hormone releasing hormone. [Letter]
  337. Birth control. [Controle da natalidade.]
  338. Birth control: clinics are major source of care for poor teenagers, and for more affluent.
  339. Birth spacing and family limitation: a critique of the Dupaquier-Lachiver Technique for detecting birth control form family reconstitution data.
  340. Births and induced abortions averted by the sterilization achievement of the Korean National Family Planning Program.
  341. Bleeding and contraceptive methods. [Hemorragies et methodes contraceptives.]
  342. Bleeding and ovulation control with use of a small contraceptive vaginal ring releasing levonorgestrel and estradiol.
  343. The Bohol culture: implications for health and family planning promotion.
  344. The Bohol Project: its relevance to the national health and family planning projects.
  345. The Bohol Project: progress report on an experiment to improve rural health and family planning in the Philippines.
  346. Bohol Province Maternal and Child Health-Based Family Planning Project: fourth annual report 1978.
  347. A book about birth control.
  348. Brazilian government supports family planning.
  349. Breast cancer and oral contraceptive therapy in premenopausal women.
  350. Budget process behind schedule - again: family planning funds appear secure.
  351. Calabar rural maternal child health/family planning project: extending health care coverage throughout village clinics.
  352. The Calabar Rural MCH/FP Project: 1975-1979: What we have learned about family planning.
  353. Cancer of the cervix in oral contraceptive and IUD users.
  354. Carbohydrate metabolism in women receiving d-norgestrel for postcoital contraception.
  355. Cardiovascular disease and oral contraceptives: a reappraisal of vital statistics data.
  356. Cardiovascular risks and oral contraceptives.
  357. Caries prevalence and oral contraception.
  358. A case for integrated food, nutrition and family planning programmes.
  359. A case of hepatic adenoma during oral contraceptive use: resection with a laser scalpel. [Ein Fall von Leberadenom unter Antikonzeptiva: Resektion mit dem Laserskalpell.]
  360. Case-control study of oral contraceptive pills and endometrial cancer.
  361. Catalog of family planning materials, supplement-September 1979.
  362. Catalog of family planning materials.
  363. Catechol-O-methyltransferase activity in erythrocytes of women taking oral contraceptive steroids.
  364. CCC tablets reports: a contraceptive agent.
  365. Celioscopy: indications and limitations in contraception and sterility. [Coelioscopie: indications et limites en contraception et sterilite.]
  366. Cerebral abscess associated with an intrauterine contraceptive device.
  367. Cerebral arterial ischaemic incidents in young women taking oral contraceptives: with reference to 19 cases. [Les accidents ischemiques arteriels cerebraux de la femme jeune sous contraceptifs oraux: a propos de 19 observations.]
  368. Cerebrovascular accidents among users of oral contraceptives: an analysis of Japanese cases.
  369. Cervical cap's profitability as contraceptive device for United States firms.
  370. Cervical mucus and natural family planning.

     

  371. The challenge and response to family planning.
  372. Changes in emotional reactions during the use of hormonal contraceptives.
  373. Changes in the cervical mucus pattern in women on oral contraceptives and intrauterine contraceptive device.
  374. Changes in thyroid function with oral contraceptives (author's transl) [Modificaciones de la funcion tiroidea con los contraceptivos orales.]
  375. Changes of the retinal vascular system during long-term use of oral contraceptives (author's transl) [Zabuzenia wukladzie naczyniowym siatkowki w przebiegu dlugotrwalego stosowania doustnych srodkow antykoncepcyjnych.]
  376. Changing attitude towards family planning: a status study.
  377. Changing patterns of fertility: the impact of contraceptive technology on a Maya village.
  378. Chen Muhua outlines significance of planned parenthood.
  379. Chinese approaches to family planning.
  380. The Chinese experience (with family planning)
  381. The choice of a combined oral contraceptive.
  382. Choice of contraception and contraceptive technology.
  383. Choice of hormonal contraception. [Therapie mit Ovulationshemmern.]
  384. Cholestasis in pregnancy, after oral contraceptives, and as an idiopathic condition.
  385. Cholestatic jaundice in women taking simultaneously triacetyloleandomycin and oral contraceptives. (Letter) [Ictere cholestatique chez des femmes prenant simultanement de la triacetyloleandomycine et des contraceptives oraux.]
  386. Chorea induced by oral contraceptives.
  387. A chromogenic and immunologic determination of alpha 2-AT III and antiplasmin in plasma in subject under oral hormone contraceptive treatment (author's transl) [Considerazioni sul dosaggio cromogenico ed immunologico de'antitrombina IIIe dell'antiplasmin in soggetti in trattamento con contraccettivi ormonali orali.]
  388. Chromosome abnormalities in oral contraceptive breakthrough pregnancies.
  389. The church and family planning.
  390. Cicloxilic acid and the bile lipids in oral contraceptive users.
  391. Cigarette smoking, alcohol intake, and oral contraceptives: relationships to lipids and lipoproteins in adolescent school-children.
  392. Clinical - effectiveness studies of vaginal contraceptives.
  393. A clinical appraisal of a medicated polyurethane sponge used for contraception.
  394. Clinical aspects of intrauterine contraception: circumspection 1976.
  395. clinical experiences with intrauterine contraceptive steroid delivery systems.
  396. Clinical observation on long-acting oral contraceptives--a report of 43,373 medical cases.
  397. Clinical pharmacology of contraceptive steroids: report on a Workshop Conference held in Igls, Austria, May 4-7, 1978.
  398. Clinical pharmacology of the steroidal oral contraceptives.
  399. A clinical study of the intrauterine contraceptive device.
  400. Clinical trial of a contraceptive foaming tablet: a preliminary report.
  401. Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol.
  402. Clinical trial of a progestogen/estrogen combination in family planning. [Estudio clinico de un compuesto progestage-no/estrogeno, en planificacion familiar.]
  403. Clinical trial of the combined contraceptive preparation, Ovidon. [Klinichno izpitvane na kominiraniia protivozachatuchen preparat Ovidon.]
  404. Clinical trial on reversible male contraceptive with long-acting sex hormones.
  405. Clinical trial with a contraceptive vaginal ring.
  406. The second national family planning and population survey in Singapore 1977.
  407. Secondary effects of oral contraceptives.
  408. Selection and management of contraceptives in the adolescent patient.
  409. Self-esteem, locus of control, and adolescent contraception.
  410. Self-sufficiency in family planning: Japan.
  411. Sensibility of pituitary, gonadal and thyroid function in adolescence without and after hormonal contraception. [Sensibilite hypophysaire, gonadale et thyroidienne chez l'adolescente, avant et apres contraception hormonale.]
  412. Serious liver diseases in women on hormonal contraceptives. [Zavazna Joterni Onemocneni u zen pri Hormonalni Anticoncepci.]
  413. Serum bile acids in women taking combination contraceptives.
  414. Serum lipid studies in women using combination type of oral contraceptives.
  415. Serum lipids in cases of oral contraceptives.
  416. Serum vitamin A and retinal-binding protein in malnourished women treated with oral contraceptives: effects of estrogen dose and duration of treatment.
  417. Serum vitamin A and retinol-binding protein in malnourished women treated with oral contraceptives: effects of estrogen dose and duration of treatment.
  418. Several characteristics of women family planning acceptors at Hasan Sadikin Hospital, Bandung. [Beberapa karakteristik ibu-ibu peserta keluarga berencana di Rumah Sakit Hasan Sadikin Bandung.]
  419. Several effects of oral contraceptive use. [Beberapa pengaruh penggunaan kontrasepsi oral.]
  420. Sex and contraception before marriage: a study of attitudes and experience of never-married youth in Melbourne, Australia.
  421. Sex education, family planning and teenage sexuality. [Educacion sexual, planificacion familiar y sexualidad juvenil.]
  422. Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids.
  423. Sex hormones and related compounds, including oral contraceptives.
  424. Sex without contraception.
  425. Sex, contraception, and fertility attitudes and behavior: an overview.
  426. Sex, contraception, and fertility attitudes and behaviour: an overview.
  427. Sexuality and contraception: studies of 420 university students concerning the correlation between menarche, beginning of sexual activity, and contraception. [Sessulita e contraccezione: indagine su 420 studentesse universitarie sulla correlazione tra menarca, inizio dell'attivita sessuale e contraccezione.]
  428. Sichuan adopts family planning measures.
  429. Side effects of oral contraceptives.
  430. Side effects of oral contraceptives. [Nebenwirkungen oraler Kontrazeptiva.]
  431. The significance of social factors, motivation and personality in long-term contraception.
  432. Silimarin in pregnancy and during hormonal contraceptive management: blood chemistry and ultrastructural findings on the experimental model. [La silimarina in gravidanza e nel trattamento contraccettivo ormonale: rilievi ematochimici ed ultratsrutturali su modello sperimentale.]
  433. Simplified health actions and family planning 1978.
  434. Sister-chromatid exchanges in oral contraceptive users.
  435. Six in 10 U.S. Catholic hospitals provide family planning: 1 in 5 offers medical sterilization.
  436. Small problems of contraception: lengthening of the menstrual period due to the IUD. [Petits problemes de la contraception: allongement des regles du au sterilet.]
  437. The social and psychological aspects of family planning.
  438. Social control and oral contraceptives.
  439. Social family-planning customs in India (Editorial) [Les usages sociaux du planning familial en Inde.]
  440. Social marketing of contraceptive products.
  441. Teaching of contraception in French Medical Schools. [L'enseignement de la contraception dans les facultes de medecine francaises.]
  442. Teaching of family planning at medical nursing and midwifery schools in certain countries of the region: report on a study.
  443. The teaching of family planning in Mexican medical schools. [La ensenanza de la planificacion familiar en las escuelas de medicina en Mexico.]
  444. Technical aspects of contraception.
  445. Teenage birth control: the case for the condom.
  446. Teenage family planning: maximizing client utilization and minimizing community resistance.
  447. Teenage sexual behaviour: perceptive and behavioral outcomes associated with receipt of family planning services.
  448. Teenage women in the USA: sex, contraception, pregnancy, fertility, and maternal and infant health.
  449. Telephone hotlines spread family planning information in Asia.
  450. A test of knowledge of contraceptive methods: pharmacists and pharmacy students.
  451. Thai nurses' family planning project expands into nationwide service program.
  452. Thailand Contraceptive Prevalence Survey: country report 1979.
  453. Thailand National Family Planning Program evaluation.
  454. Thailand national family planning program evaluation.
  455. Therapy with oral contraceptive steroids and antibiotics.
  456. Therapy with oral contraceptive steroids and antibiotics.
  457. Three contraceptive acceptance strategies.
  458. Three-month injectable microcapsule contraceptive system.
  459. Thrombocyte function in relation to the long term application of medroxyprogesterone acetate as a female contraceptive agent.
  460. Thromboelastography in contraceptive treatment with estroprogestogens (lynestrenol 2.5 mg plus mestranol 0.075 mg) [La tromboelastografia en el tratamiento anovulatorio con estroprogestinicos (Linestrenol 2.5 mg. plus Mestranol 0.075 mg)]
  461. Thromboglobulin levels and oral contraception. [Letter]
  462. Thrombosis and oral contraceptives.
  463. Thrombotic thrombocytopoenic purpura during oral contraceptive treatment. (Letter)
  464. Tianjin holds family planning conference.
  465. Time and motion study of family planning clinic attached to a university hospital.
  466. Tomorrow's contraceptives: yesterday's problem?
  467. Total family planning.
  468. Toward greater reproductive freedom: Wisconsin's new Family Planning Act.
  469. Traditional birth attendants as hilot maternal and child health-family planning aides in Philippine rural communities.
  470. Trainer's manual for instructor training in natural family planning.
  471. Training and manpower development in surgical contraceptive programs.
  472. The training and supervision of non-physicians in the delivery of family planning services.
  473. Training facilities in population and family planning in the Western Hemisphere Region.
  474. Training family planning field workers by behaviour modelling.
  475. Training in family planning for nurses and midwives.
  476. Training of the medical profession in family planning.
  477. Transfer of contraceptive steroids to human milk.
  478. Transient postoperative hypertension: role of obesity and oral contraceptives. [Letter]
  479. Treatment possibilities of early stages of venous insufficiency caused by oral contraceptives. [Behandlungsmoeglichkeit des Fruehstadiums der venoesen Insuffizienz bei Einnahme von Antikonzeptiva.]
  480. Trends in surgical contraception in Mainland Tanzania.
  481. Trial of a topical antibacterial, antimycotic and anti-venereal contraceptive association. [Studio su un'associazione farmacologica per uso topico ad azione anticoncezionale, antibatterica, antimicotica e profilattica per le malattie veneree.]
  482. Trip report. Technical assistance to the Contraceptive Retail Sales Program, Kingston, Jamaica, 26 November -7 December 1979.
  483. Tryptophan and tyrosine availability and oral contraceptives.
  484. Tubal and uterine secretions; the possibilities for contraceptive attack.
  485. Tunisia family planning services: mid-term evaluation, part one.
  486. Tunisia: rural contraceptive distribution project has impact.
  487. Two cases of benign liver tumors in women on oral contraceptives (author's Transl) [A propos de deux cas de tumeurs hepatiques benignes chez des femmes sous contraceptifs oraux.]
  488. Types of non-physician personnel suitable for family planning service delivery: the variety and the factors affecting use.
  489. Ultrastructural changes in endometrium of women exposed to progesterone releasing intrauterine contraceptive devices for more than five years.
  490. Ultrastructural morphometric investigations on human platelets after long-term ingestion of oral contraceptives.
  491. University medical doctors' and medical students' knowledge and use of contraceptive methods. [Conoscenza ed utilizzazione delle metodiche contraccettive da parte dei medici universitari e studenti in medicina.]
  492. Unmet needs in maternal and child health/family planning in Kenya.
  493. Update on birth control in general practice. pt 5. Contraception and cardiovascular diseases. [Mises au ponit sur la regulation des naissances en pratique medicale courante. Pt. 5. Contraception et affections cardio-vasculaires.]
  494. Use and acceptance of the paper pill: a novel approach to oral contraception.
  495. The use of a contraceptive vaginal ring governed by the pattern of individual uterine bleeding.
  496. The use of a modified Gravigard intrauterine device in nulliparous patients previously intolerant of intrauterine contraception.
  497. The use of contraceptive prevalence surveys to evaluate the family planning program in El Salvador and other countries in Latin America. (Tables)
  498. The use of contraceptive prevalence surveys to evaluate the family planning program in El Salvador.
  499. Use of contraceptives in 1975 among Danish women 18-49 years.
  500. Use of contraceptives prior to and after conception and exposure to other fetal hazards.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.